Stanley Schwartz
University of Pennsylvania
Philadelphia
USA
Name/email consistency: high
- Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. Schwartz, S. Curr. Med. Res. Opin (2008)
University of Pennsylvania
Philadelphia
USA
Name/email consistency: high